Posted by Michael Wonder on 30 Apr 2017
Agenda for 3 May 2017 TC meeting
28 April 2017 - HAS has posted the agenda for the next scheduled TC meeting.
The Transparency Commission will consider the reimbursement of:
- Pembrolizumab (Keytruda)
- Ataluren (Translarna)
